Sort
46,585 grants matching “heart failure”
Surgery to prevent postinfarction ventricular remodeling
$592,975Robert C Gorman · University Of Pennsylvania · R01 · FY2009 · HL
Acute Kidney Injury: A Novel Risk Factor for Cardiovascular Events
$592,894Kathleen D Liu · University Of California, San Francisco · R01 · FY2014 · DK
Cell Adhesion and Trafficking as a Therapeutic Target in Allotransplantation
$592,875Allan D. Kirk · Emory University · U19 · FY2012 · AI
WHISH-2-Prevent Heart Failure Study
$592,832Charles B Eaton · Memorial Hospital Of Rhode Island · R01 · FY2017 · HL
Understanding and Manipulating Phospholipase C and G Protein beta gamma subunit Signaling Networks
$592,803Alan V. Smrcka · University Of Michigan At Ann Arbor · R35 · FY2022 · GM
Understanding and Manipulating Phospholipase C and G Protein beta gamma subunit Signaling Networks
$592,803Alan V. Smrcka · University Of Michigan At Ann Arbor · R35 · FY2021 · GM
Understanding and Manipulating Phospholipase C and G Protein beta gamma subunit Signaling Networks
$592,803Alan V. Smrcka · University Of Michigan At Ann Arbor · R35 · FY2020 · GM
Understanding and Manipulating Phospholipase C and G Protein beta gamma subunit Signaling Networks
$592,803Alan V. Smrcka · University Of Michigan At Ann Arbor · R35 · FY2019 · GM
A-Adrenergic Axis in Hypertrophy and Heart Failure
$592,789University Of Cincinnati · P50 · FY2005 · HL
Imaging Hypoxic Pulmonary Vasoconstriction in the Aging Lung with Proton MRI
$592,751Susan R Hopkins · University Of California, San Diego · R01 · FY2016 · HL
VASCULAR EFFECTS OF DIETARY SALT IN HUMANS WITH SALT-RESISTANT BP
$592,737William B Farquhar · University Of Delaware · R01 · FY2019 · HL
VASCULAR EFFECTS OF DIETARY SALT IN HUMANS WITH SALT-RESISTANT BP
$592,737William B Farquhar · University Of Delaware · R01 · FY2020 · HL
VASCULAR EFFECTS OF DIETARY SALT IN HUMANS WITH SALT-RESISTANT BP
$592,737William B Farquhar · University Of Delaware · R01 · FY2021 · HL
Eicosanoid Profiles as Determinants of HFpEF
$592,670Jennifer E Ho · Massachusetts General Hospital · R01 · FY2021 · HL
The role of obscurin and Obsl1 as key determinants for diastolic function
$592,656Yoshitake Cho · University Of California, San Diego · R01 · FY2022 · HL
Investigating the role of H2A.Z dynamics in regulating cardiac lineage commitment
$592,653Laurie A Boyer · Massachusetts Institute Of Technology · R01 · FY2019 · HL
Clonal Hematopoiesis of Indeterminate Potential in Chronic Kidney Disease Patients
$592,640Tanika Nicole Kelly · University Of Illinois At Chicago · R01 · FY2024 · DK
Project 2 - Molecular and Cellular Mechanisms of Cardiometabolic Toxicity of VOCs
$592,550Sanjay Srivastava · University Of Louisville · P42 · FY2025 · ES
Pilot Trial of Carvedilol in Alzheimer's Disease
$592,548Giulio Maria Pasinetti · Icahn School Of Medicine At Mount Sinai · R01 · FY2012 · AG
Cardiac dysfunction after ischemic AKI in mice
$592,494Sarah Faubel · University Of Colorado Denver · R01 · FY2021 · HL
Cardiac dysfunction after ischemic AKI in mice
$592,494Sarah Faubel · University Of Colorado Denver · R01 · FY2023 · HL
Cardiac dysfunction after ischemic AKI in mice
$592,494Sarah Faubel · University Of Colorado Denver · R01 · FY2022 · HL
Phase II Clinical Trial to Evaluate the Benefits of Postconditioning in STEMI
$592,481Jay H Traverse · University Of Minnesota · R01 · FY2011 · HL
Navigation Services to Avoid Rehospitalization (NavSTAR) among substance abusers
$592,474Jan Gryczynski · Friends Research Institute, Inc. · R01 · FY2015 · DA
Gut microbiome, aging and cardiometabolic diseases in American Indians
$592,471Jinying Zhao · University Of Florida · R01 · FY2024 · AG